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In addition, the viral load in this 
study appeared to be comparative-
ly high. These results suggest that 
some sapovirus genotypes are more 
virulent than others. Similar ﬁ  ndings 
were obtained with norovirus infec-
tions around the world; strains be-
longing to norovirus GII/4 were the 
most prevalent in many countries. 
Although several recombinant sapo-
virus strains have been identiﬁ  ed and 
found to be the cause of increased 
numbers of infections in some coun-
tries (1,5), they were not observed in 
this study. Increased sapovirus sur-
veillance and reporting are needed to 
shed some more light on this poorly 
understood virus.
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Importation of 
West Nile Virus 
Infection from 
Nicaragua to Spain 
To the Editor: We report the case 
of a 51-year-old Spanish missionary 
who had lived Nicaragua (Managua) 
from 2004 to 2006. He had no other 
notable travel history during that pe-
riod. In June 2006, he noticed malaise 
and nausea, followed by abrupt onset 
of fever (39°C), headache, cervical 
pain, and right hemiparesis. He was 
admitted to a local hospital in Nicara-
gua, at which time routine results of 
hematologic and biochemistry tests 
were within normal limits, except for 
mild neutrophilia. After cerebral mag-
netic resonance imaging (MRI), a di-
agnosis of ischemic cerebrovascular 
accident was made. He was treated 
with aspirin and ceftriaxone for an 
oropharyngeal infection.
Because neurologic symptoms 
persisted, 13 days later he was trans-
ferred to a hospital in Madrid, Spain. 
At that time, physical examination 
showed neck stiffness, a diminished 
level of consciousness, right ﬂ  accid 
hemiparesis, and facial weakness. Pe-
ripheral blood examination showed 
only mild neutrophilia. Cerebrospi-
nal ﬂ  uid (CSF) analysis showed a 65 
mg/dL glucose level (blood glucose 
140), proteins 136 g/dL, and 18 cells/
mm3 (mainly lymphocytes). Serologic 
test results for HIV, hepatitis B virus, 
hepatitis C virus, syphilis, Toxoplasma 
spp., and Brucella spp., and CSF cul-
tures for mycobacterial, bacterial, and 
fungal infections were all negative. Re-
sults of a computed tomographic scan 
of the brain were within normal limits. 
MRI showed nonspeciﬁ  c  abnormal 
intensity of white matter signal. Elec-
trophysiologic studies showed severe 
axonal motor neuropathy and mod-
erate sensitive axonal neuropathy in 
the right upper limb. Gammaglobulin 
was administered intravenously for 5 
days; the patient improved slightly. At 
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discharge, the diagnosis was of “Guil-
lain-Barré–like syndrome.” He was 
admitted to our Tropical Medicine 
Unit in Madrid, 160 days after onset 
of intial symptoms. West Nile virus 
(WNV) infection was suspected, and 
diagnostic tests were performed on all 
available samples. The ﬁ  rst serum (S1) 
and CSF samples obtained 13 days 
after onset of symptoms were sent to 
us for testing. A second serum sample 
(S2) was obtained at 160 days.
The CSF was tested for ﬂ  avivirus 
by using a generic PCR (1) and found 
negative, and for WNV immunoglob-
ulin (Ig) G and IgM (Focus, Cypress, 
CA, USA)  as previously described 
(2) and showed positive results for 
both immunoglobulins (Table). Serum 
samples were studied by ELISA for 
WNV IgG and IgM (Focus), and posi-
tive results were obtained for IgG to 
WNV in both samples and for IgM in 
S1. By a plaque reduction neutraliza-
tion assay (PRNT) with 100 50% in-
fection units of WNV (Eg-101 strain), 
positive titers of 256 in S1 and 64 in 
S2 were obtained (Table).
S1 and CSF were subsequently 
titrated for WNV IgG by ELISA and 
for WNV antibodies by PRNT. Spe-
ciﬁ  c WNV IgG or total antibodies/al-
bumin indices of 3.54 and 7.0, respec-
tively, were obtained.
Serum samples were also assayed 
for IgG and IgM by ELISA against 
dengue virus (Panbio, Brisbane, 
Queensland, Australia) and tick-borne 
encephalitis virus (Siemens, Mars-
burg, Germany). Positive results were 
obtained for IgG to both viruses; titers 
did not vary, which suggests cross-re-
activity with WNV or prior infection 
due to another ﬂ  avivirus.
The causative role of WNV was 
conﬁ  rmed by the following factors: 1) 
the detection of WNV-speciﬁ  c  IgM, 
in the absence of IgM response to 
the other ﬂ   avivirus, in combination 
with the variation of PRNT titer in S1 
and S2; 2) the evidence of intrathecal 
WNV IgG by ELISA and WNV an-
tibodies by PRNT, according to well 
established cutoff values (3); and 3) 
the detection of WNV-speciﬁ  c IgM in 
CSF. The ﬁ  nal diagnosis was meningo-
encephalitis with acute ﬂ  accid paraly-
sis due to WNV infection with right 
upper limb paraparesis and muscular 
atrophy as sequelae (online Appendix 
Figure, available from www.cdc.gov/
EID/content/14/7/1171-appG.htm).
WNV is an arbovirus, family Fla-
viviridae, ﬁ  rst detected in 1937. It is 
maintained worldwide in an enzootic 
cycle, transmitted primarily between 
avian hosts and mosquito vectors. 
Mosquitoes of the genus Culex are the 
main vectors. Humans and horses are 
accidental secondary hosts (4). WNV 
is now widely distributed in Africa, 
Asia, the Middle East, Europe, and 
the Americas. The ﬁ  rst epidemics of 
WNV encephalitis were reported in the 
early 1950s in Egypt and Israel, then 
in France (1960s) and in South Africa 
(1970s). During the past 10 years, sev-
eral WNV outbreaks in humans have 
been reported in the Mediterranean ba-
sin and in southern Europe (5,6). In the 
Americas, the ﬁ  rst cases were reported 
in New York City in 1999 (7), and the 
spread of WNV to large areas of the 
United States, Canada, Mexico, Cen-
tral America, and the Caribbean was 
demonstrated in subsequent years. The 
case reported here also represents a new 
case of imported WNV infection in Eu-
rope and documents an imported case 
acquired in Central America (8–10) 
WNV infection in animals, main-
ly in birds and horses, has been docu-
mented in Mexico, the Caribbean, and 
areas of South America. Birds, in par-
ticular, have been implicated in spread-
ing WNV during migratory events in 
Europe, Asia, Africa, and the Middle 
East. WNV could thus potentially be 
introduced by the same mechanism in 
Central and South America, resulting 
in possible transmission to humans in 
countries like Nicaragua (7).
In conclusion, the possibility 
should be considered of new cases of 
WNV infection arising outside classic 
areas of high risk. Clinicians should 
be aware of the possibility of imported 
WNV to request speciﬁ  c tests in symp-
tomatic patients.
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Table. Serologic results for antibodies to West Nile virus (WNV), dengue virus (DV), and tick-borne encephalitis virus (TBEV)* 
WNV
ELISA PRNT DV ELISA  TBEV ELISA  Sample/
d after onset  IgG† IgG‡ IT-IgG§ IgM† Ab‡ IT  Ab¶  IgG† IgM† IgG† IgM†
S1/13 3.5 65,000 3.54 3.6 256 7.0 4.8 0.3 59.5 0.1
CSF/13 4,000 Pos# 32
S2/160 3.2 16,000 0.8 64 4.5 0.2 27 0.1
*PRNT, plaque reduction neutralization assay; Ig, immunoglobulin; Ab, antibodies; IT, intrathecal; S1, first serum sample, obtained 13 days after onset of 
symptoms;  CSF, cerebrospinal fluid; Pos, positive; S2, second serum sample, obtained 160 days after onset of symptoms. 
†Results expressed as the ratio of sample absorbance to cutoff value (positive >1.0). 
‡Titer.
§IT production of WNV IgG (ELISA).  
¶IT production of WNV antibodies (PRNT). 
#CSF tested diluted 1:2.  LETTERS
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Outbreak of 
Pertussis, Kabul, 
Afghanistan 
To  the Editor: Infectious dis-
eases are the main cause of illness for 
armed forces in conﬂ  ict (1), resulting 
in decreases in operational efﬁ  ciency. 
The International Security Assistance 
Force (ISAF) in Afghanistan is a mul-
tinational force operating under the 
auspices of the North Atlantic Treaty 
Organization (NATO). As part of 
ISAF, French troops operate in Kabul 
and its surroundings, within a 70-km 
radius. French medical facilities con-
sist of a French ﬁ  eld hospital and a 
primary care center. The facilities sup-
port 4,000 soldiers, 1,048 of whom are 
French.
Troop disease, including acute re-
spiratory disease (ARD), is routinely 
monitored through French Army and 
NATO surveillance systems. We re-
port an outbreak of ARD in the multi-
national force in which pertussis cases 
were identiﬁ   ed by using laboratory 
tests and epidemiologic criteria.
In November 2006, a signiﬁ  cant 
increase of ARD was detected in sol-
diers of different nationalities (Figure), 
with a 10-fold increase among French 
troops at week 51. Patients with per-
sistent cough or dyspnea were referred 
to the ﬁ  eld hospital, in a nonrandom-
ized manner, and those with a 2-week 
history of cough underwent serologic 
tests. Samples were sent to France and 
were analyzed at Hôpital Saint Anne, 
Toulon, France. Immunoglobulin (Ig) 
G antibodies to Bordetella pertussis 
antigens (pertussis toxin, ﬁ  lamentous 
hemagglutinin, and adenylcyclase) 
were determined by a Western blot 
assay (MarDx Diagnostics, Carlsbad, 
CA, USA). Recent infection was diag-
nosed by ﬁ  nding high levels of anti-
bodies to pertussis toxin compared to 
results for standardized positive and 
negative samples, in concurrence with 
the fact that no soldier had been vacci-
nated against pertussis after childhood. 
IgG and IgA antibodies to Chlamydia 
pneumoniae were determined by a 
semiquantitative method that assessed 
samples’ absorbance value in optical 
density (SeroCP Quant IgG and Quant 
IgA, Savyon Diangostics, Ashdod, Is-
rael). Recent infection to Mycoplasma 
pneumoniae was assessed by detecting 
IgM antibodies with a speciﬁ  c enzyme 
immunoassay (Platelia Mycoplasma 
pneumoniae, Biorad, Hercules, CA, 
USA) and by using a semiquantitative 
method to detect IgM and IgG anti-
bodies with patented gelatin particles 
sensitized with cell membrane com-
ponents of M. pneumoniae (Serodia 
Myco II, Fujirebio, Malvern, PA, 
USA). Coxiella burnetii infection was 
assessed by indirect immunoﬂ  uores-
cence assay (Coxiella burnetii Spot IF, 
bioMérieux, Marcy l’Etoile, France).
Statistical analysis was performed 
with Epi Info v3.4 software package 
(Centers for Disease Control [CDC], 
Atlanta, GA, USA). Quantitative vari-
ables were compared by using the 
Kruskall-Wallis test.
From the third week of Decem-
ber 2006 until the third week of Janu-
ary 2007, 209 French soldiers sought 
treatment at the French medical facili-
ties for stereotyped acute febrile re-
spiratory infection, which represents 
a cumulative attack rate of 20% on 
clinical grounds. Thirty-nine French 
soldiers and 10 non-French soldiers 
or local civilian workers were then re-
ferred to the ﬁ  eld hospital. All patients 
had a 24-h history of fever >38.5°C 
and nonspeciﬁ  c ear, nose, and throat 
symptoms, mainly a sore throat. Cough 
was unremarkable, without whoops. 
Fourteen of the 49 patients were hos-
pitalized for severe dyspnea. Median 
age was the same for inpatients (26 
[range 20–57] years) and outpatients 
(36 [range 21–53] years, p = 0.15).
Twenty-seven blood samples were 
taken, 24 from French troops, 2 from 
British troops, and 1 from Polish pa-
tients. Six patients, including 3 French 
soldiers, had recent pertussis. No dif-
ference in age was found between 
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